These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

682 related articles for article (PubMed ID: 9286775)

  • 1. "Refractoriness" of airflow obstruction associated with isolated lymphocytic bronchiolitis/bronchitis in pulmonary allografts.
    Ross DJ; Marchevsky A; Kramer M; Kass RM
    J Heart Lung Transplant; 1997 Aug; 16(8):832-8. PubMed ID: 9286775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yield of surveillance bronchoscopy for acute rejection and lymphocytic bronchitis/bronchiolitis after lung transplantation.
    Chakinala MM; Ritter J; Gage BF; Lynch JP; Aloush A; Patterson GA; Trulock EP
    J Heart Lung Transplant; 2004 Dec; 23(12):1396-404. PubMed ID: 15607670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of heart-lung transplant recipients with prospective, serial transbronchial biopsies and pulmonary function studies.
    Starnes VA; Theodore J; Oyer PE; Billingham ME; Sibley RK; Berry G; Shumway NE; Stinson EB
    J Thorac Cardiovasc Surg; 1989 Nov; 98(5 Pt 1):683-90. PubMed ID: 2554067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiologic definitions of obliterative bronchiolitis in heart-lung and double lung transplantation: a comparison of the forced expiratory flow between 25% and 75% of the forced vital capacity and forced expiratory volume in one second.
    Patterson GM; Wilson S; Whang JL; Harvey J; Agacki K; Patel H; Theodore J
    J Heart Lung Transplant; 1996 Feb; 15(2):175-81. PubMed ID: 8672521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severity of lymphocytic bronchiolitis predicts long-term outcome after lung transplantation.
    Glanville AR; Aboyoun CL; Havryk A; Plit M; Rainer S; Malouf MA
    Am J Respir Crit Care Med; 2008 May; 177(9):1033-40. PubMed ID: 18263803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transbronchial biopsy in heart and lung transplantation: clinicopathologic correlations.
    Pomerance A; Madden B; Burke MM; Yacoub MH
    J Heart Lung Transplant; 1995; 14(4):761-73. PubMed ID: 7578187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Special problems after lung transplantation: walking a tightrope between infection and graft rejection].
    Gaspert A; Boehler A; Weder W; Speich R; Vogt P
    Schweiz Med Wochenschr; 2000 Jun; 130(25):944-51. PubMed ID: 10909721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of presumed and proven acute rejection following six months of lung transplant survival.
    Kesten S; Maidenberg A; Winton T; Maurer J
    Am J Respir Crit Care Med; 1995 Oct; 152(4 Pt 1):1321-4. PubMed ID: 7551389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yield of surveillance transbronchial biopsies performed beyond two years after lung transplantation.
    Kesten S; Chamberlain D; Maurer J
    J Heart Lung Transplant; 1996 Apr; 15(4):384-8. PubMed ID: 8732597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is lymphocytic bronchiolitis a marker of acute rejection? An analysis of 2,697 transbronchial biopsies after lung transplantation.
    Burton CM; Iversen M; Scheike T; Carlsen J; Andersen CB
    J Heart Lung Transplant; 2008 Oct; 27(10):1128-34. PubMed ID: 18926405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients.
    Kumar D; Husain S; Chen MH; Moussa G; Himsworth D; Manuel O; Studer S; Pakstis D; McCurry K; Doucette K; Pilewski J; Janeczko R; Humar A
    Transplantation; 2010 Apr; 89(8):1028-33. PubMed ID: 20075787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for the development of obliterative bronchiolitis after lung transplantation.
    Girgis RE; Tu I; Berry GJ; Reichenspurner H; Valentine VG; Conte JV; Ting A; Johnstone I; Miller J; Robbins RC; Reitz BA; Theodore J
    J Heart Lung Transplant; 1996 Dec; 15(12):1200-8. PubMed ID: 8981205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of oral ganciclovir in prevention of cytomegalovirus infection in post-kidney transplant patients.
    Ahsan N; Holman MJ; Yang HC
    Clin Transplant; 1997 Dec; 11(6):633-9. PubMed ID: 9408699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-transplant baseline FEV1 and the development of bronchiolitis obliterans syndrome: an important confounder?
    Burton CM; Iversen M; Mortensen J; Carlsen J; Andersen CB; Milman N; Scheike T
    J Heart Lung Transplant; 2007 Nov; 26(11):1127-34. PubMed ID: 18022078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection.
    Sarahrudi K; Estenne M; Corris P; Niedermayer J; Knoop C; Glanville A; Chaparro C; Verleden G; Gerbase MW; Venuta F; Böttcher H; Aubert JD; Levvey B; Reichenspurner H; Auterith A; Klepetko W
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1126-32. PubMed ID: 15052212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined cytomegalovirus prophylaxis in lung transplantation: effects on acute rejection, lymphocytic bronchitis/bronchiolitis, and herpesvirus infections.
    Solidoro P; Libertucci D; Delsedime L; Ruffini E; Bosco M; Costa C; Rinaldi M; Baldi S
    Transplant Proc; 2008; 40(6):2013-4. PubMed ID: 18675117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the different histologic lesions observed in transbronchial biopsy for the diagnosis of acute rejection. Clinicopathologic correlations during the first 6 months after lung transplantation.
    Colombat M; Groussard O; Lautrette A; Thabut G; Marrash-Chahla R; Brugière O; Mal H; Lesèche G; Fournier M; Degott C
    Hum Pathol; 2005 Apr; 36(4):387-94. PubMed ID: 15892000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection.
    Stewart S; Fishbein MC; Snell GI; Berry GJ; Boehler A; Burke MM; Glanville A; Gould FK; Magro C; Marboe CC; McNeil KD; Reed EF; Reinsmoen NL; Scott JP; Studer SM; Tazelaar HD; Wallwork JL; Westall G; Zamora MR; Zeevi A; Yousem SA
    J Heart Lung Transplant; 2007 Dec; 26(12):1229-42. PubMed ID: 18096473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate can halt the progression of bronchiolitis obliterans syndrome in lung transplant recipients.
    Dusmet M; Maurer J; Winton T; Kesten S
    J Heart Lung Transplant; 1996 Sep; 15(9):948-54. PubMed ID: 8889991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchiolitis obliterans syndrome and early human cytomegalovirus DNAaemia dynamics after lung transplantation.
    Westall GP; Michaelides A; Williams TJ; Snell GI; Kotsimbos TC
    Transplantation; 2003 Jun; 75(12):2064-8. PubMed ID: 12829913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.